Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes
NHS hospitals in England used £83,112,666 of indicative cost of Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is up 4.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £83,112,666 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.